Sponsors and exhibitors

To get further information click here.

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. For inspiring stories about the promise of biotechnology, visit CSL.com/Vita and follow us on Twitter.com/CSLBehring.

To get further information click here.

Genostis AG develops, produces, and distributes plates and screws for osteosynthesis.

The innovative philosophy of "SWISS GENERIC OSTEOSYNTHESIS" stands for proven implant design based on the AO philosophy, well-established technologies, and easy-to-use instruments. High-quality automated production 100% in Switzerland and lean structures enable the company to offer fair prices significantly lower than other premium brands, without compromising on quality!

By using Genostis implants, a surgeon can continue to work with his usual surgical technique, maintain the quality of fracture care and still meet the cost-saving demands imposed on him nowadays by hospital managements and health insurances.

To get further information click here.